Citadel Advisors’s CASTLIGHT HEALTH, INC. CSLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-213,778
| Closed | -$329K | – | 15240 |
|
|
2021
Q4 | $329K | Buy |
+213,778
| New | +$353K | ﹤0.01% | 10724 |
|
|
2021
Q3 | – | Sell |
-34,912
| Closed | -$68.4K | – | 15170 |
|
|
2021
Q2 | $92K | Sell |
34,912
-87,223
| -71% | -$162K | ﹤0.01% | 12984 |
|
|
2021
Q1 | $184K | Sell |
122,135
-12,775
| -9% | -$22.2K | ﹤0.01% | 11803 |
|
|
2020
Q4 | $176K | Sell |
134,910
-16,518
| -11% | -$18.6K | ﹤0.01% | 9831 |
|
|
2020
Q3 | $171K | Buy |
+151,428
| New | +$166K | ﹤0.01% | 8929 |
|
|
2020
Q2 | – | Sell |
-119,090
| Closed | -$88.5K | – | 10783 |
|
|
2020
Q1 | $86K | Buy |
119,090
+9,074
| +8% | +$10.1K | ﹤0.01% | 8730 |
|
|
2019
Q4 | $146K | Sell |
110,016
-122,900
| -53% | -$171K | ﹤0.01% | 8381 |
|
|
2019
Q3 | $329K | Buy |
232,916
+128,976
| +124% | +$257K | ﹤0.01% | 7433 |
|
|
2019
Q2 | $335K | Sell |
103,940
-134,603
| -56% | -$464K | ﹤0.01% | 7421 |
|
|
2019
Q1 | $894K | Buy |
238,543
+174,077
| +270% | +$553K | ﹤0.01% | 5788 |
|
|
2018
Q4 | $140K | Sell |
64,466
-15,652
| -20% | -$38.8K | ﹤0.01% | 8095 |
|
|
2018
Q3 | $216K | Buy |
80,118
+33,412
| +72% | +$118K | ﹤0.01% | 8100 |
|
|
2018
Q2 | $198K | Sell |
46,706
-80,001
| -63% | -$301K | ﹤0.01% | 7898 |
|
|
2018
Q1 | $462K | Buy |
126,707
+30,703
| +32% | +$114K | ﹤0.01% | 6012 |
|
|
2017
Q4 | $360K | Sell |
96,004
-48,932
| -34% | -$196K | ﹤0.01% | 6157 |
|
|
2017
Q3 | $623K | Buy |
144,936
+39,766
| +38% | +$164K | ﹤0.01% | 4994 |
|
|
2017
Q2 | $437K | Buy |
105,170
+713
| +0.7% | +$2.78K | ﹤0.01% | 5304 |
|
|
2017
Q1 | $381K | Buy |
104,457
+5,696
| +6% | +$20K | ﹤0.01% | 5506 |
|
|
2016
Q4 | $489K | Buy |
98,761
+29,541
| +43% | +$134K | ﹤0.01% | 4933 |
|
|
2016
Q3 | $288K | Sell |
69,220
-112,858
| -62% | -$461K | ﹤0.01% | 5735 |
|
|
2016
Q2 | $721K | Sell |
182,078
-19,699
| -10% | -$77.3K | ﹤0.01% | 3992 |
|
|
2016
Q1 | $672K | Sell |
201,777
-95,277
| -32% | -$313K | ﹤0.01% | 4005 |
|
|
2015
Q4 | $1.27M | Sell |
297,054
-26,075
| -8% | -$112K | ﹤0.01% | 3290 |
|
|
2015
Q3 | $1.36M | Buy |
323,129
+287,141
| +798% | +$1.81M | ﹤0.01% | 3409 |
|
|
2015
Q2 | $293K | Buy |
35,988
+7,845
| +28% | +$65.4K | ﹤0.01% | 5779 |
|
|
2015
Q1 | $218K | Buy |
28,143
+26,877
| +2,123% | +$230K | ﹤0.01% | 6079 |
|
|
2014
Q4 | $15K | Sell |
1,266
-11,115
| -90% | -$133K | ﹤0.01% | 7991 |
|
|
2014
Q3 | $161K | Sell |
12,381
-8,813
| -42% | -$116K | ﹤0.01% | 5957 |
|
|
2014
Q2 | $322K | Buy |
+21,194
| New | +$344K | ﹤0.01% | 4982 |
|
Citadel Advisors's CSLT Position: Q1 2022 in Review
Citadel Advisors sold out of CASTLIGHT HEALTH, INC. (CSLT) in Q1 2022, closing a stake of 213,778 shares — an estimated $329K sold.
Citadel Advisors first reported a position in CSLT in Q2 2014 and held it in 29 quarters. The position peaked at $1.36M in Q3 2015. 0 funds tracked by Wall St. Rank hold CSLT as of Q1 2022.
- Citadel Advisors reported no remaining CASTLIGHT HEALTH, INC. position as of Q1 2022 after selling out during the quarter.
- Citadel Advisors sold 213,778 CASTLIGHT HEALTH, INC. shares in Q1 2022, an estimated $329K.
- Citadel Advisors first reported a position in CASTLIGHT HEALTH, INC. in Q2 2014 and held it in 29 quarters.
- Citadel Advisors's CASTLIGHT HEALTH, INC. position peaked at $1.36M in Q3 2015.
- 0 funds tracked by Wall St. Rank held CASTLIGHT HEALTH, INC. as of Q1 2022.
Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.